Moderna has now swung violently in both directions for three straight sessions on the same unchanged clinical news, and the ...

The story has been refreshed with the latest market price action and a revised headline. Elon Musk said Wednesday that mRNA ...

A groundbreaking mRNA cancer drug significantly reduces melanoma recurrence in a large trial, marking a major advancement in ...

In light of recent wins for mRNA vaccine makers, UCSC RNA Center Co-Director Jeremy Sanford describes the versatility of the ...

This flu season, some people will have a choice between getting the standard flu shot or the new mRNA flu vaccine, according ...

In a new study, scientists from Johns Hopkins Medicine report that an experimental mRNA-based platform has the potential to ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 20% in the morning session after investors took profits as the ...

New mRNA vaccines and studies are demonstrating a flood of medical breakthroughs. But how much will the federal government ...

An experimental mRNA vaccine tailored to patients' DNA reduced melanoma recurrence risk in early trials, offering new hope for treatment.

The vaccine, when combined with the immunotherapy drug Keytruda, reduced skin cancer recurrence and the results were ...

Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at bay opens a ​new avenue of ...

Moderna (NASDAQ:MRNA | MRNA Price Prediction) shares have crashed 20% as of 12:00 PM ET on Thursday after delivering one of ...